Trevi Therapeutics Aktie
13,30
USD
+0,22
USD
+1,68
%
13,29
USD
+0,21
USD
+1,57
%
Werbung
Trevi Therapeutics Aktie Analyse
| 03.06.19 | Trevi Therapeutics Outperform | BMO Capital Markets | |
| 03.06.19 | Trevi Therapeutics Buy | Needham & Company, LLC |
Werbung
Werbung